老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Propanc Biopharma, Inc.

1.87
-0.0800-4.10%
盘后：1.880.0100+0.53%17:48 EDT
成交量：28.54万
成交额：53.75万
市值：2,358.41万
市盈率：-0.04
高：2.06
开：1.98
低：1.80
收：1.95
52周最高：30.00
52周最低：0.0002
股本：1,261.18万
流通股本：340.45万
量比：0.45
换手率：8.38%
股息：- -
股息率：- -
每股收益(TTM):-51.7796
每股收益(LYR):-1.7983
净资产收益率：-767.20%
总资产收益率：-298.55%
市净率：1.30
市盈率(LYR):-1.04

数据加载中...

总览公司新闻公告
2020/01/17

重要事件披露

8-K - Current report
2019/12/12

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2019/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/10/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2019/10/08

重要事件披露

8-K - Current report
2019/09/09

重要事件披露

8-K - Current report
2019/08/06

重要事件披露

8-K - Current report
2019/07/10

重要事件披露

8-K - Current report
2019/07/01

重要事件披露

8-K - Current report
2019/06/21

重要事件披露

8-K - Current report
2019/06/20

SEC问询函

CORRESP [Cover] - Correspondence
2019/06/14

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2019/05/30

重要事件披露

8-K - Current report
2019/05/23

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2019/05/15

重要事件披露

8-K - Current report
2019/05/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/03/05

SEC问询函

CORRESP [Cover] - Correspondence
2019/02/25

重要事件披露

8-K - Current report
2019/02/25

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2019/02/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
更多